Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
infectious arthritis
MeSH D001170 - infectious arthritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007239:
Infections
1 Company
1 Drug
$
Success rate
D001168:
Arthritis
15 Companies
8 Drugs
$
Success rate
D001170:
Infectious arthritis
37 Companies
7 Drugs
$
Success rate
D016918:
Reactive arthritis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
50
%
1/2
Phase 2
0
%
0/0
Phase 3
100
%
2/2
Approved:
2
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Ciprofloxacin
Merck & Co
Cilastatin
,
Imipenem
,
Relebactam
Bayer
Ciprofloxacin
Dr Reddys Laboratories
Ciprofloxacin
,
Dexamethasone
Sun Pharmaceutical Industries
Dexamethasone
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use